申请人:——
公开号:US04766210A1
公开(公告)日:1988-08-23
Antihypertensive compounds of the structure ##STR1## wherein: n is an integer from 0 to 2 inclusive, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 are independently hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 2 to 6 carbon atoms, alkynyl having from 2 to 6 carbon atoms, cycloalkyl having from 3 to 16 carbon atoms, phenyl, benzyl, tolyl, naphthyl, phenethyl, indanyl, tetrahydronaphthyl, decahydronaphthyl, pyridyl, quinolyl, pyrrolidyl, pyrrolyl, morpholinyl, thiomorpholinyl, furyl, furfuryl, tetrahydrofurfuryl, benzimidazole, thienyl, imidolyl, or tetrahydroindolyl, and where the R.sub.1 to R.sub.7 groups are alkyl, said groups carrying a substituent selected from hydroxy, alkoxy, amino, carboxy, or carbalkoxy, the alkyl group in alkoxy and carbalkoxy having from 1 to 6 carbon atoms, or R.sub.2 taken together with R.sub.3 and the carbons to which they are attached is tetrahydronapthyl or phenyl, and when phenyl R.sub.1 and R.sub.4 are absent, or R.sub.6 and R.sub.7 taken together with the carbon to which R.sub.6 is attached and the nitrogen to which R.sub.7 is attached form a heterocycle selected from pyrrolidyl, thiazolidine, tetrahydro-isoquinoline, thiomorpholine, or 2,2,5,5-tetramethylthiazolidinie, and Y is .dbd.O, .dbd.S, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.
结构式为##STR1##的降压化合物,其中:n是0至2的整数,R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5、R.sub.6和R.sub.7独立地为氢、碳数为1到6的烷基、碳数为2到6的烯基、碳数为2到6的炔基、碳数为3到16的环烷基、苯基、苄基、
甲苯基、
萘基、苯乙基、
茚基、四氢
萘基、十氢
萘基、
吡啶基、
喹啉基、
吡咯烷基、
吡咯基、吗啉基、
硫代吗啉基、
呋喃基、
呋喃甲基、
四氢呋喃基、
苯并咪唑基、
噻吩基、
咪唑基或四氢
吲哚基,其中R.sub.1至R.sub.7基为烷基,所述基带有从羟基、烷氧基、
氨基、羧基或羧烷氧基中选择的取代基,烷氧基和羧烷氧基中的烷基含有1到6个碳原子,或R.sub.2与R.sub.3及它们所连接的碳一起取代为四氢
萘基或苯基,当苯基R.sub.1和R.sub.4不存在时,或R.sub.6和R.sub.7与R.sub.6所连接的碳和R.sub.7所连接的氮一起形成从
吡咯基、
噻唑环、
四氢异喹啉、
硫代吗啉或2,2,5,5-四甲基
噻唑环中选择的杂环,且Y为.dbd.O、.dbd.S、.dbd.NR.sub.1、.dbd.NOR.sub.1或.dbd.N--NH.sub.2,其中R.sub.1与上述定义相同。